Cyanotech Corp CYAN
We take great care to ensure that the data presented and summarized in this overview for CYANOTECH CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CYAN
Top Purchases
Top Sells
About CYAN
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Insider Transactions at CYAN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Collette Nicole Kakuk Chief Strategic Comml Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-24.92%
|
$0
$0.4 P/Share
|
|
Feb 18
2025
|
Collette Nicole Kakuk Chief Strategic Comml Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+38.45%
|
-
|
|
Feb 18
2025
|
Amy Beth Nordin VP, HR, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-12.87%
|
$0
$0.4 P/Share
|
|
Feb 18
2025
|
Amy Beth Nordin VP, HR, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,400
+26.89%
|
-
|
|
Feb 18
2025
|
Jennifer M. Johansen VP, Quality, Regulatory & Govt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,201
-11.94%
|
$0
$0.4 P/Share
|
|
Feb 18
2025
|
Jennifer M. Johansen VP, Quality, Regulatory & Govt |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+24.13%
|
-
|
|
Feb 18
2025
|
Glenn Jensen VP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,340
-4.89%
|
$0
$0.4 P/Share
|
|
Feb 18
2025
|
Glenn Jensen VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,570
+11.53%
|
-
|
|
Feb 18
2025
|
Gerald R Cysewski |
SELL
Payment of exercise price or tax liability
|
Direct |
1,464
-0.99%
|
$0
$0.4 P/Share
|
|
Feb 18
2025
|
Gerald R Cysewski |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+2.58%
|
-
|
|
Oct 01
2024
|
Michael A / Davis Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,158
+0.88%
|
$0
$0.76 P/Share
|
|
Oct 01
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.76 P/Share
|
|
Sep 30
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.76 P/Share
|
|
Sep 27
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.77 P/Share
|
|
Sep 26
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.77 P/Share
|
|
Sep 25
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.77 P/Share
|
|
Sep 24
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.73 P/Share
|
|
Sep 23
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.77 P/Share
|
|
Sep 20
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.77 P/Share
|
|
Sep 19
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.74 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 29.8K shares |
|---|---|
| Open market or private purchase | 337K shares |
| Grant, award, or other acquisition | 196K shares |
| Payment of exercise price or tax liability | 11.2K shares |
|---|